Found: 50
Select item for more details and to access through your institution.
Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase F-FDG PET/CT.
- Published in:
- European Radiology, 2015, v. 25, n. 7, p. 2015, doi. 10.1007/s00330-015-3609-3
- By:
- Publication type:
- Article
PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/6945415
- By:
- Publication type:
- Article
Prediction of Chemotherapy Response of Osteosarcoma Using Baseline <sup>18</sup>F-FDG Textural Features Machine Learning Approaches with PCA.
- Published in:
- Contrast Media & Molecular Imaging, 2019, p. 1, doi. 10.1155/2019/3515080
- By:
- Publication type:
- Article
Estimation of an Image Biomarker for Distant Recurrence Prediction in NSCLC Using Proliferation-Related Genes.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2794, doi. 10.3390/ijms24032794
- By:
- Publication type:
- Article
Radioimmunotherapy with <sup>131</sup>I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 6, p. 690, doi. 10.1111/ajco.13932
- By:
- Publication type:
- Article
Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using 18 F-FDG PET/CT, EZRIN , and KI67.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2671, doi. 10.3390/cancers13112671
- By:
- Publication type:
- Article
Usefulness of increased F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement.
- Published in:
- Skeletal Radiology, 2015, v. 44, n. 4, p. 529, doi. 10.1007/s00256-014-2063-7
- By:
- Publication type:
- Article
Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma.
- Published in:
- Skeletal Radiology, 2013, v. 42, n. 12, p. 1673, doi. 10.1007/s00256-013-1714-4
- By:
- Publication type:
- Article
A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00746-1
- By:
- Publication type:
- Article
Early response monitoring of neoadjuvant chemotherapy using [18F]FDG PET can predict the clinical outcome of extremity osteosarcoma.
- Published in:
- EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-019-0588-4
- By:
- Publication type:
- Article
Metastasis risk prediction model in osteosarcoma using metabolic imaging phenotypes: A multivariable radiomics model.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0225242
- By:
- Publication type:
- Article
Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 3, p. 654
- By:
- Publication type:
- Article
Prognostic value of F-FDG uptake by regional lymph nodes on pretreatment PET/CT in patients with resectable colorectal cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 12, p. 2203, doi. 10.1007/s00259-014-2840-5
- By:
- Publication type:
- Article
The combination of FDG PET and dynamic contrast-enhanced MRI improves the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 10, p. 1852, doi. 10.1007/s00259-014-2797-4
- By:
- Publication type:
- Article
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential F-FDG PET/CT and MRI.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 8, p. 1553, doi. 10.1007/s00259-014-2746-2
- By:
- Publication type:
- Article
F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 5, p. 728, doi. 10.1007/s00259-013-2344-8
- By:
- Publication type:
- Article
Machine Learning Model for Lymph Node Metastasis Prediction in Breast Cancer Using Random Forest Algorithm and Mitochondrial Metabolism Hub Genes.
- Published in:
- Applied Sciences (2076-3417), 2021, v. 11, n. 7, p. 2897, doi. 10.3390/app11072897
- By:
- Publication type:
- Article
Characteristics of thyroid incidentalomas detected by pre-treatment [<sup>18</sup>F]FDG PET or PET/CT in patients with cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2012, v. 23, n. 1, p. 43, doi. 10.3802/jgo.2012.23.1.43
- By:
- Publication type:
- Article
Head‐to‐head comparison of <sup>18</sup>F‐FP‐CIT and <sup>123</sup>I‐FP‐CIT for dopamine transporter imaging in patients with Parkinson's disease: A preliminary study.
- Published in:
- Synapse, 2018, v. 72, n. 7, p. 1, doi. 10.1002/syn.22032
- By:
- Publication type:
- Article
A comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262371
- By:
- Publication type:
- Article
A comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262371
- By:
- Publication type:
- Article
A comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF and <sup>18</sup>F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262371
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL-PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.234799
- By:
- Publication type:
- Article
Initial Metabolic Tumor Volume Measured by <sup>18</sup>F-FDG PET/CT Can Predict the Outcome of Osteosarcoma of the Extremities.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 10, p. 1725, doi. 10.2967/jnumed.112.117697
- By:
- Publication type:
- Article
Combination of <sup>18</sup>F-FDG PET/CT and Diffusion-Weighted MR Imaging as a Predictor of Histologic Response to Neoadjuvant Chemotherapy: Preliminary Results in Osteosarcoma.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 7, p. 1053, doi. 10.2967/jnumed.112.115964
- By:
- Publication type:
- Article
Extravasation of Hydroxymethylene Diphosphonate-Induced Subcutaneous Inflammation, Histologically Demonstrated in BALB/c Mice.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 10, p. 1573, doi. 10.2967/jnumed.110.078774
- By:
- Publication type:
- Article
Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of <sup>225</sup>Ac-DOTA-rituximab using <sup>64</sup>Cu-DOTA-rituximab.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparisons of <sup>131</sup>I-rituximab treatment responses in patients with aggressive lymphoma and indolent lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
An enhanced treatment effect can be expected from a higher serum thyroglobulin level after radioactive iodine therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A new method for apparent diffusion coefficient measurement using sequential (18)F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A new method for apparent diffusion coefficient measurement using sequential F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast.
- Published in:
- Annals of Nuclear Medicine, 2013, v. 27, n. 8, p. 720, doi. 10.1007/s12149-013-0737-1
- By:
- Publication type:
- Article
Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer.
- Published in:
- Annals of Nuclear Medicine, 2012, v. 26, n. 10, p. 777, doi. 10.1007/s12149-012-0640-1
- By:
- Publication type:
- Article
Positron emission tomographic findings in a tuberculous brain abscess.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Radioimmunotherapy with (131)I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Repeated radioimmunotherapy with I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 945, doi. 10.1007/s00280-013-2087-z
- By:
- Publication type:
- Article
Positron emission tomography (PET) radiotracers for prostate cancer imaging.
- Published in:
- Abdominal Radiology, 2020, v. 45, n. 7, p. 2165, doi. 10.1007/s00261-020-02427-4
- By:
- Publication type:
- Article
Combination of 131I-trastuzumab and lanatoside C enhanced therapeutic efficacy in HER2 positive tumor model.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92460-0
- By:
- Publication type:
- Article
Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77875-5
- By:
- Publication type:
- Article
Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153281
- By:
- Publication type:
- Article
PET/MRI and Novel Targets for Breast Cancer.
- Published in:
- Biomedicines, 2024, v. 12, n. 1, p. 172, doi. 10.3390/biomedicines12010172
- By:
- Publication type:
- Article
Deep Learning-Based Delayed PET Image Synthesis from Corresponding Early Scanned PET for Dosimetry Uptake Estimation.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 19, p. 3045, doi. 10.3390/diagnostics13193045
- By:
- Publication type:
- Article
Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma Using Convolutional Neural Network of Tumor Center 18 F-FDG PET Images.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 11, p. 1976, doi. 10.3390/diagnostics11111976
- By:
- Publication type:
- Article
The role of <sup>18</sup>F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using <sup>131</sup>I-rituximab as consolidation therapy.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0273839
- By:
- Publication type:
- Article
A Phase II Study of 131 I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.
- Published in:
- Clinical Medicine Insights: Oncology, 2023, p. 1, doi. 10.1177/11795549231218082
- By:
- Publication type:
- Article
A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.
- Published in:
- Clinical Medicine Insights: Oncology, 2023, v. 17, p. 1, doi. 10.1177/11795549231218082
- By:
- Publication type:
- Article
Prognostic Significance of Pretreatment F-FDG PET/CT in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma Treated by Radioimmunotherapy Using <sup>131</sup>I-Rituximab.
- Published in:
- Acta Haematologica, 2013, v. 130, n. 2, p. 74, doi. 10.1159/000346436
- By:
- Publication type:
- Article
A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 1, p. 95, doi. 10.1007/s00259-020-04883-y
- By:
- Publication type:
- Article
<sup>18</sup>F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 1, p. 178, doi. 10.1007/s00259-019-04483-5
- By:
- Publication type:
- Article